SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
About SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Takeda
4
Stallergenes Greer
3
Baxalta now part of Shire
2
Ferring Pharmaceuticals
2
Genentech, Inc.
2
Mannkind Corporation
2
Merz Pharmaceuticals GmbH
2
Boehringer Ingelheim
1
Celldex Therapeutics
1
Cochlear
1
Clinical Trials at SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
During the past decade, SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on
average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
2005-06-01
2008-10-01
Completed
2,053
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
2006-02-01
2008-09-01
Completed
677
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
2008-11-01
2010-06-01
Completed
400
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
2009-01-01
2011-12-01
Terminated
821
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
2010-11-01
2012-10-01
Completed
574
The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis
2011-07-01
2013-12-01
Completed
25
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,068
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Takeda" with 4 trials
sponsored, "Stallergenes Greer" with 3 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored and "Ferring Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi"
#1 collaborator was "Aptuit" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Cenduit LLC" with 1 trials as a collaborator and "PHT Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
According to Clinical.Site data, the most researched conditions in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi" are
"Asthma" (6 trials), "Colitis, Ulcerative" (3 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Crohn's Disease" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi" in a lesser frequency.
Clinical Trials Intervention Types at SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
Most popular intervention types in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi" are "Drug" (24 trials), "Biological" (7 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Lebrikizumab" (3 trials), "HYQVIA" (2 trials), "MSTT1041A" (2 trials) and "Mavenclad®" (2 trials). Other intervention names were less common.
Clinical Trials Genders at SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
The vast majority of trials in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi" are
31 trials for "All" genders.
Clinical Trials Status at SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
Currently, there are NaN active trials in "SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi has several departments that took part in Clinical trials: "SPZOZ Uniwersytecki Szp. Klin. nr1 im.N.Barlickiego UM;Oddzial Kliniczny Neurologii" - 3 trials, "SPZOZ Uniwersytecki SK nr 1 im N. Barlickiego UM w Lodzi; Oddz. Klin. Gastroenter. Og. i Onk." - 2 trials